Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
Howard H. Yang(Vanderbilt University), Harold L. Moses(National Center for Toxicological Research), Anna Chytil(Vanderbilt University), Mary Aakre(Vanderbilt University), David P. Carbone(Vanderbilt University), Lynn M. Matrisian(Pancreatic Cancer Action Network), Xiubao Ren(Tianjin Medical University Cancer Institute and Hospital), Jianhua Huang(Vanderbilt University), Agnieszka E. Gorska(Vanderbilt University), P. Charles Lin(Vanderbilt University), Ann Richmond(Monroe Carell Jr. Children's Hospital)
Cited by 917
Related Papers
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
|Cancer Research|2014|7.2k
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
|Science|2002|2.7k
Metalloproteinases and their inhibitors in matrix remodeling
|Trends in Genetics|1990|1.6k
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
|Journal of Clinical Oncology|2000|1.6k
The matrix‐degrading metalloproteinases
|BioEssays|1992|1.4k